Webinar: Using mass cytometry, imaging, and machine learning to understand malignant brain tumor biology
Rebecca Ihrie, PhD
A central goal in single-cell cancer research is to identify phenotypically distinct cells that have prognostic significance for patients. This need is acute in brain tumor glioblastoma, where changes in gene sequence, copy number or transcript expression can define patient or cell subgroups, but these subgroups are not associated with large differences in clinical outcomes.
Rebecca Ihrie, PhD, will present recent work using suspension mass cytometry (used in CyTOF® instruments) and Imaging Mass Cytometry™ to
She will also discuss ongoing work using these approaches to understand how tumor contact with a brain stem cell niche may alter the properties of cancer and immune cells in these tumors and impact patient survival.
In this webinar, sponsored by Fluidigm, attendees will learn about
For Research Use Only. Not for use in diagnostic procedures.